Do Opioids Have a Role in the Management of Knee and Hip Osteoarthritis?
Researchers assessed pain relief and functional improvement in patients receiving opioids for knee or hip osteoarthritis.
Pain Management
Contextual Effect Enhances Management of Knee Osteoarthritis
Researchers aimed to clarify the role of contextual effect in widely used nonpharmacologic, nonsurgical treatments for knee osteoarthritis by conducting a literature review of knee osteoarthritis trials.
CDC: 10.7% of US Adults Used Prescription Pain Medications From 2015 to 2018
In 2015 to 2018, 10.7% of US adults aged 20 years or older used one or more prescription pain medications.
Tanezumab Improves Pain, Function in Chronic Low Back Pain
For patients with chronic low back pain, tanezumab 10 mg significantly improves pain and function.
ASIPP Releases Guidelines for Diagnostic and Therapeutic Facet Joint Interventions
The ASIPP has published comprehensive, evidence-based guidelines for performing diagnostic and therapeutic facet joint interventions in the management of chronic spinal pain.
Unapproved Cannabidiol, Curcumin Injectables for Multiple Disorders Recalled
Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.
Racial Differences Seen in Pain Management for Children With Long Bone Fractures
There are racial differences in pain management and pain outcomes for children seen in the emergency department for long-bone fractures.
Antirheumatic Therapy Decreases Opioid Use in Patients With Early Inflammatory Arthritides
Researchers assessed the effect of the opioid epidemic in Finnish patients with early inflammatory arthritides.
Q&A: Applications of a Novel Joint Preservation Technology in Glenohumeral Osteoarthritis
In this interview, Gregory P Nicholson, MD, discusses the applications of a novel joint preservation technology in glenohumeral osteoarthritis.
FDA Approves NDA for Diclofenac Sodium Topical Gel 1% for Arthritis Pain
Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults ≥18 years old.
-
Loading...
-
Loading...
Next post in Pain Management
